Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.

Acta Biomaterialia
Magdalena M Samojlik, C L Stabler

Abstract

The effective suppression of adaptive immune responses is essential for the success of allogeneic cell therapies. In islet transplantation for Type 1 Diabetes, pre-existing autoimmunity provides an additional hurdle, as memory autoimmune T cells mediate both an autoantigen-specific attack on the donor beta cells and an alloantigen-specific attack on the donor graft cells. Immunosuppressive agents used for islet transplantation are generally successful in suppressing alloimmune responses, but dramatically hinder the widespread adoption of this therapeutic approach and fail to control memory T cell populations, which leaves the graft vulnerable to destruction. In this review, we highlight the capacity of biomaterials to provide local and nuanced instruction to suppress or alter immune pathways activated in response to an allogeneic islet transplant. Biomaterial immunoisolation is a common approach employed to block direct antigen recognition and downstream cell-mediated graft destruction; however, immunoisolation alone still permits shed donor antigens to escape into the host environment, resulting in indirect antigen recognition, immune cell activation, and the creation of a toxic graft site. Designing materials to decrease anti...Continue Reading

References

Jul 1, 1992·Journal of Biomedical Materials Research·H IwataT Akutsu
Apr 1, 1991·Journal of Microencapsulation·H A ClaytonR F James
Jan 1, 1989·Diabetes·D E SutherlandR K Sibley
Sep 1, 1994·Journal of Biomedical Materials Research·H IwataF Ito
Jan 1, 1994·Immunology Today·D A Shoskes, K J Wood
Jan 1, 1993·Acta Diabetologica·H A ClaytonN J London
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·H AuchinclossL H Glimcher
Oct 22, 1998·Surgery·A M D'AlessandroH W Sollinger
Feb 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·U SiebersT Zekorn
Mar 31, 1999·Immunology Today·D S Gould, H Auchincloss
May 8, 1999·Transplantation·R P LanzaW L Chick
Jul 23, 1999·Annals of the New York Academy of Sciences·R G Gill
Jul 6, 2000·Immunopharmacology·T S Mele, P F Halloran
Aug 16, 2000·Advanced Drug Delivery Reviews·B Ríhová
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·Z DaiF G Lakkis
Oct 18, 2000·The Journal of Clinical Investigation·B A PietraR G Gill
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·E J SuchinL A Turka
Sep 18, 2001·Seminars in Nephrology·A Tejani, L Emmett
Feb 21, 2002·Journal of Biomaterials Science. Polymer Edition·M V Risbud, R R Bhonde
May 2, 2002·Cell·Jeffrey C Rathmell, Craig B Thompson
Jul 2, 2003·Journal of Biomedical Materials Research. Part a·Makarand V RisbudRamesh R Bhonde
Apr 2, 2004·Nature Reviews. Immunology·Camillo Ricordi, Terry B Strom
Jul 23, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Dominike SauvéClaude Daniel
Dec 4, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Valérie F Duvivier-KaliGordon C Weir
Dec 16, 2004·Transplantation·Kim S JonesReginald M Gorczynski
Feb 15, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Jonathan P PearlAllan D Kirk
Feb 22, 2005·Current Drug Targets. Inflammation and Allergy·Antonella Naldini, Fabio Carraro
Jun 2, 2005·Journal of the American Chemical Society·Paul RoachCarole C Perry
Jun 29, 2005·Diabetes·Edmond A RyanA M James Shapiro
Dec 6, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dong Yun LeeYoungro Byun
Jan 26, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Michal Pearl-YafeNadir Askenasy
Apr 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·David C NeujahrLaurence A Turka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.